{"id":"W2110544330","title":"Binding of yohimbine and imipramine to platelets in depressive illness","authors":["Louise Braddock","Philip J. Cowen","J.M. Elliott","Sheila Fraser","K. Stump"],"venue":"Psychological Medicine","year":1986,"doi":"10.1017/s0033291700011776","url":"https://doi.org/10.1017/s0033291700011776","openalex":"https://openalex.org/W2110544330","abstract":"Synopsis Radioligand binding to intact platelets was carried out in antidepressant-free patients and the 1 mg dexamethasone suppression test (DST) was performed. There were no differences in binding characteristics between patients and controls for either [H]yohimbine or [H]imipramine. There were no differences in binding between patients classified as endogenous using the Newcastle Scale, compared with non-endogenous patients, and no difference between DST suppressors and non-suppressors. The severity of depression did not affect binding values. After 4â€“6 weeks antidepressant treatment [H]yohimbine binding was significantly reduced but [H]imipramine binding was unaffected.","is_oa":false,"oa_status":null,"network":{"internal_citations":0,"cited_by_count":40},"references":50,"networkCitations":0,"seed":false}